Evidence map›Paper›PMID 41915721›Full record

ReviewPLOS digital health2026

Recent advances in corneal specular microscopy image analysis through artificial intelligence.

Andres G Marrugo, Fernando Quintero, Alejandro Tello, Angélica M Prada, Virgilio Galvis, Lenny A Romero

Abstract readReview
In one paragraph

Review in PLOS digital health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Repeatability and reproducibility of corneal endothelial measurements using the topcon SP-1P specular microscope.Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Andres G MarrugoEscuela de Ingeniería, Arquitectura y Diseño, Universidad Tecnologica de Bolivar, Cartagena, Colombia.ORCID https://orcid.org/0000-0003-2413-7645
Fernando QuinteroEscuela de Ingeniería, Arquitectura y Diseño, Universidad Tecnologica de Bolivar, Cartagena, Colombia.
Alejandro TelloCentro Oftalmológico Virgilio Galvis, Floridablanca, Colombia.
Angélica M PradaCentro Oftalmológico Virgilio Galvis, Floridablanca, Colombia.
Virgilio GalvisCentro Oftalmológico Virgilio Galvis, Floridablanca, Colombia.
Lenny A RomeroDirección de Ciencias Básicas, Universidad Tecnologica de Bolivar, Cartagena, Colombia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Although conventional automated analysis of corneal specular microscopy images has historically been limited by reproducibility challenges in the presence of corneal guttae, recent advances in artificial intelligence (AI) have significantly enhanced its diagnostic potential in such cases. This review explores the integration of AI techniques for analyzing specular microscopy images, emphasizing the shift from classical to advanced AI methods. We highlight AI-based methodologies-supervised and unsupervised learning-that have significantly enhanced the accuracy of in vivo human corneal endothelium analysis. The paper also discusses the challenges in data collection, emphasizing ethical considerations and the need for high-quality datasets. Additionally, we explore novel AI-derived metrics and their implications in enhancing diagnostic precision, particularly in Fuchs endothelial corneal dystrophy. The review concludes with insights into the future direction of AI in specular microscopy, highlighting its increasing relevance in ocular healthcare and the potential to overcome longstanding limitations in the field.

Identifiers

PMID41915721
PMCPMC13038023

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.